Mahzi Therapeutics Announces First Patient Dosed in Phase 1/2 UNITE Study of MZ-1866 for Pitt Hopkins Syndrome
First Investigational Gene Therapy for Pitt Hopkins Syndrome Intended to Address Underlying Disease Biology SOUTH SAN FRANCISCO, Calif., Feb. 25,...
Read moreDetails